By Blair Childs, Senior Vice President, Public Affairs
Premier is pleased to see to see the Food and Drug Administration’s (FDA) critical medication and device list of products required for patient care ian emergency, natural disaster, or other urgent situation. Premier has long advocated to FDA and Congress for such a list.
Premier encourages FDA to now actively consult with healthcare providers and their supply chain partner GPOs on the thoroughness and completeness of the list for the acute and non-acute space. This is especially true given that GPOs like Premier are working to ensure that drugs are made available through programs such as ProvideGx.
We urge FDA to treat today’s list as draft and immediately seek feedback from the private healthcare sector. Moving forward, provider input should be sought regularly to ensure the list remains dynamic and is updated as emerging technologies arise, practice guidelines are updated, and best practices are identified.
About Premier, Inc.
Premier, Inc. (NASDAQ: PINC) is a leading healthcare improvement company, uniting an alliance of more than 4,100 U.S. hospitals and health systems and approximately 200,000 other providers and organizations to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, and consulting and other services, Premier enables better care and outcomes at a lower cost. Premier plays a critical role in the rapidly evolving healthcare industry, collaborating with members to co-develop long-term innovations that reinvent and improve the way care is delivered to patients nationwide. Headquartered in Charlotte, N.C., Premier is passionate about transforming American healthcare. Please visit Premier’s news and investor sites on www.premierinc.com; as well as Twitter, Facebook, LinkedIn, YouTube, Instagram and Premier’s blog for more information about the company.